Skip to main content

Advertisement

SpringerLink
Log in

Coronary flow reserve in patients with resistant hypertension

  • Original Paper
  • Published:
Clinical Research in Cardiology Aims and scope Submit manuscript

Abstract

Resistant hypertension is associated with increased risk for cardiovascular events. Coronary flow reserve (CFR) is impaired in patients with hypertension and an independent predictor of cardiac mortality. However, there are no published data on CFR in the subset of treatment-resistant hypertension. The aim of this study was to assess CFR in patients with resistant hypertension. Twenty-five consecutive patients with primary resistant hypertension, scheduled for renal denervation, 25 matched patients with controlled hypertension, and 25 healthy controls underwent transthoracic colour Doppler echocardiography at rest and during adenosine infusion. Patients with hypertension were pair-matched with regard to age, sex, ischemic heart disease, diabetes mellitus, smoking status, and body-mass index. Healthy controls were selected according to age and sex. Mean flow velocity was measured in the left coronary anterior descending artery. Baseline mean flow velocities were similar in patients with controlled and resistant hypertension. CFR was significantly lower in patients with resistant hypertension as compared to individuals with non-resistant hypertension (2.7 ± 0.6 vs. 3.1 ± 0.8; p = 0.03). Systolic office blood pressure was significantly higher in patients with resistant hypertension (169 ± 20 vs. 144 ± 21 mm Hg; p < 0.01). Heart rate, ventricular mass, and ejection fraction were similar in the two groups. Healthy controls showed significantly lower baseline velocity, higher CFR, and lower blood pressure as compared to hypertensives. Resistant hypertension was associated with impaired CFR as compared to individuals with non-resistant hypertension indicating impaired cardiac microvascular function which may contribute to the increased risk of adverse outcome in patients with resistant hypertension.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Cuspidi C, Macca G, Sampieri L, Michev I, Salerno M, Fusi V et al (2001) High prevalence of cardiac and extracardiac target organ damage in refractory hypertension. J Hypertens 19(11):2063–2070

    Article  CAS  PubMed  Google Scholar 

  2. Pimenta E, Calhoun DA (2012) Resistant hypertension: incidence, prevalence, and prognosis. Circulation 125(13):1594–1596

    Article  PubMed  PubMed Central  Google Scholar 

  3. Daugherty SL, Powers JD, Magid DJ, Tavel HM, Masoudi FA, Margolis KL et al (2012) Incidence and prognosis of resistant hypertension in hypertensive patients. Circulation 125(13):1635–1642

    Article  PubMed  PubMed Central  Google Scholar 

  4. Hozumi T, Yoshida K, Akasaka T, Asami Y, Ogata Y, Takagi T et al (1998) Noninvasive assessment of coronary flow velocity and coronary flow velocity reserve in the left anterior descending coronary artery by Doppler echocardiography: comparison with invasive technique. J Am Coll Cardiol 32(5):1251–1259

    Article  CAS  PubMed  Google Scholar 

  5. Lethen H, Tries HP, Kersting S, Lambertz H (2003) Validation of noninvasive assessment of coronary flow velocity reserve in the right coronary artery. A comparison of transthoracic echocardiographic results with intracoronary Doppler flow wire measurements. Eur Heart J 24(17):1567–1575

    Article  PubMed  Google Scholar 

  6. Cortigiani L, Rigo F, Gherardi S, Bovenzi F, Molinaro S, Picano E et al (2012) Coronary flow reserve during dipyridamole stress echocardiography predicts mortality. JACC Cardiovasc Imaging 5(11):1079–1085

    Article  PubMed  Google Scholar 

  7. Sicari R, Rigo F, Cortigiani L, Gherardi S, Galderisi M, Picano E (2009) Additive prognostic value of coronary flow reserve in patients with chest pain syndrome and normal or near-normal coronary arteries. Am J Cardiol 103(5):626–631

    Article  PubMed  Google Scholar 

  8. Cortigiani L, Rigo F, Gherardi S, Sicari R, Galderisi M, Bovenzi F et al (2007) Additional prognostic value of coronary flow reserve in diabetic and nondiabetic patients with negative dipyridamole stress echocardiography by wall motion criteria. J Am Coll Cardiol 50(14):1354–1361

    Article  PubMed  Google Scholar 

  9. Erdogan D, Yildirim I, Ciftci O, Ozer I, Caliskan M, Gullu H et al (2007) Effects of normal blood pressure, prehypertension, and hypertension on coronary microvascular function. Circulation 115(5):593–599

    Article  PubMed  Google Scholar 

  10. Tsiachris D, Tsioufis C, Dimitriadis K, Syrseloudis D, Rousos D, Kasiakogias A et al (2012) Relation of impaired coronary microcirculation to increased urine albumin excretion in patients with systemic hypertension and no epicardial coronary arterial narrowing. Am J Cardiol 109(7):1026–1030

    Article  PubMed  Google Scholar 

  11. Wittfeldt A, Emanuelsson H, Brandrup-Wognsen G, van Giezen JJJ, Jonasson J, Nylander S et al (2013) Ticagrelor enhances adenosine-induced coronary vasodilatory responses in humans. J Am Coll Cardiol 61(7):723–727

    Article  CAS  PubMed  Google Scholar 

  12. Armstrong AC, Gidding S, Gjesdal O, Wu C, Bluemke DA, Lima JA (2012) LV mass assessed by echocardiography and CMR, cardiovascular outcomes, and medical practice. JACC Cardiovasc Imaging 5(8):837–848

    Article  PubMed  PubMed Central  Google Scholar 

  13. Wendelhag I, Gustavsson T, Suurkula M, Berglund G, Wikstrand J (1991) Ultrasound measurement of wall thickness in the carotid artery: fundamental principles and description of a computerized analysing system. Clin Physiol 11(6):565–577

    Article  CAS  PubMed  Google Scholar 

  14. National Clinical Guideline C (2011) National Institute for Health and Clinical Excellence: Guidance. Hypertension: The Clinical Management of Primary Hypertension in Adults: Update of Clinical Guidelines 18 and 34. London, Royal College of Physicians (UK) National Clinical Guideline Centre

  15. Persell SD (2011) Prevalence of resistant hypertension in the United States, 2003–2008. Hypertension 57(6):1076–1080

    Article  CAS  PubMed  Google Scholar 

  16. Baumgart D, Haude M, Liu F, Ge J, Goerge G, Erbel R (1998) Current concepts of coronary flow reserve for clinical decision making during cardiac catheterization. Am Heart J 136(1):136–149

    Article  CAS  PubMed  Google Scholar 

  17. Bonetti PO, Lerman LO, Lerman A (2003) Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 23(2):168–175

    Article  CAS  PubMed  Google Scholar 

  18. Dharmashankar K, Widlansky ME (2010) Vascular endothelial function and hypertension: insights and directions. Curr Hypertens Rep 12(6):448–455

    Article  PubMed  PubMed Central  Google Scholar 

  19. Brush JE Jr, Faxon DP, Salmon S, Jacobs AK, Ryan TJ (1992) Abnormal endothelium-dependent coronary vasomotion in hypertensive patients. J Am Coll Cardiol 19(4):809–815

    Article  PubMed  Google Scholar 

  20. Ghiadoni L, Taddei S, Virdis A, Sudano I, Di Legge V, Meola M et al (1998) Endothelial function and common carotid artery wall thickening in patients with essential hypertension. Hypertension 32(1):25–32

    Article  CAS  PubMed  Google Scholar 

  21. Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE (1994) Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 24(6):1468–1474

    Article  CAS  PubMed  Google Scholar 

  22. Egashira K, Suzuki S, Hirooka Y, Kai H, Sugimachi M, Imaizumi T et al (1995) Impaired endothelium-dependent vasodilation of large epicardial and resistance coronary arteries in patients with essential hypertension. Different responses to acetylcholine and substance P. Hypertension 25(2):201–206

    Article  CAS  PubMed  Google Scholar 

  23. Rubanyi GM, Romero JC, Vanhoutte PM (1986) Flow-induced release of endothelium-derived relaxing factor. Am J Physiol 250(6 Pt 2):H1145–H1149

    CAS  PubMed  Google Scholar 

  24. Yoshizumi M, Kurihara H, Sugiyama T, Takaku F, Yanagisawa M, Masaki T et al (1989) Hemodynamic shear stress stimulates endothelin production by cultured endothelial cells. Biochem Biophys Res Commun 161(2):859–864

    Article  CAS  PubMed  Google Scholar 

  25. Brush JE Jr, Cannon RO 3rd, Schenke WH, Bonow RO, Leon MB, Maron BJ et al (1988) Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy. N Engl J Med 319(20):1302–1307

    Article  PubMed  Google Scholar 

  26. Hamasaki S, Al Suwaidi J, Higano ST, Miyauchi K, Holmes DR Jr, Lerman A (2000) Attenuated coronary flow reserve and vascular remodeling in patients with hypertension and left ventricular hypertrophy. J Am Coll Cardiol 35(6):1654–1660

    Article  CAS  PubMed  Google Scholar 

  27. Grassi G, Seravalle G, Brambilla G, Pini C, Alimento M, Facchetti R et al (2014) Marked sympathetic activation and baroreflex dysfunction in true resistant hypertension. Int J Cardiol 177(3):1020–1025

    Article  PubMed  Google Scholar 

  28. Mancia G, Grassi G (2014) The autonomic nervous system and hypertension. Circ Res 114(11):1804–1814

    Article  CAS  PubMed  Google Scholar 

  29. Dahlof B, Pennert K, Hansson L (1992) Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies. Am J Hypertens 5(2):95–110

    CAS  PubMed  Google Scholar 

  30. Fagard R, Staessen JA, Thijs L (1995) The relationships between left ventricular mass and daytime and night-time blood pressures: a meta-analysis of comparative studies. J Hypertens 13(8):823–829

    Article  CAS  PubMed  Google Scholar 

  31. Missault LH, De Buyzere ML, De Bacquer DD, Duprez DD, Clement DL (2002) Relationship between left ventricular mass and blood pressure in treated hypertension. J Hum Hypertens 16(1):61–66

    Article  CAS  PubMed  Google Scholar 

  32. Heesen WF, Beltman FW, May JF, Smit AJ, de Graeff PA, Havinga TK et al (1997) High prevalence of concentric remodeling in elderly individuals with isolated systolic hypertension from a population survey. Hypertension 29(2):539–543

    Article  CAS  PubMed  Google Scholar 

  33. Cuspidi C, Rescaldani M, Sala C, Grassi G (2014) Left-ventricular hypertrophy and obesity: a systematic review and meta-analysis of echocardiographic studies. J Hypertens 32(1):16–25

    Article  CAS  PubMed  Google Scholar 

  34. Himeno E, Nishino K, Nakashima Y, Kuroiwa A, Ikeda M (1996) Weight reduction regresses left ventricular mass regardless of blood pressure level in obese subjects. Am Heart J 131(2):313–319

    Article  CAS  PubMed  Google Scholar 

  35. Truong QA, Toepker M, Mahabadi AA, Bamberg F, Rogers IS, Blankstein R et al (2009) Relation of left ventricular mass and concentric remodeling to extent of coronary artery disease by computed tomography in patients without left ventricular hypertrophy: ROMICAT study. J Hypertens 27(12):2472–2482

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Eguchi K, Boden-Albala B, Jin Z, Rundek T, Sacco RL, Homma S et al (2008) Association between diabetes mellitus and left ventricular hypertrophy in a multiethnic population. Am J Cardiol 101(12):1787–1791

    Article  PubMed  PubMed Central  Google Scholar 

  37. Prati P, Vanuzzo D, Casaroli M, Di Chiara A, De Biasi F, Feruglio GA et al (1992) Prevalence and determinants of carotid atherosclerosis in a general population. Stroke J Cereb Circ 23(12):1705–1711

    Article  CAS  Google Scholar 

  38. Ferrieres J, Elias A, Ruidavets JB, Cantet C, Bongard V, Fauvel J et al (1999) Carotid intima-media thickness and coronary heart disease risk factors in a low-risk population. J Hypertens 17(6):743–748

    Article  CAS  PubMed  Google Scholar 

  39. Mannami T, Konishi M, Baba S, Nishi N, Terao A (1997) Prevalence of asymptomatic carotid atherosclerotic lesions detected by high-resolution ultrasonography and its relation to cardiovascular risk factors in the general population of a Japanese city: the Suita study. Stroke; J Cereb Circ 28(3):518–525

    Article  CAS  Google Scholar 

  40. Takiuchi S, Rakugi H, Fujii H, Kamide K, Horio T, Nakatani S et al (2003) Carotid intima-media thickness is correlated with impairment of coronary flow reserve in hypertensive patients without coronary artery disease. Hypertens Res 26(12):945–951

    Article  PubMed  Google Scholar 

  41. Gullu H, Erdogan D, Caliskan M, Tok D, Yildirim E, Ulus T et al (2006) Interrelationship between noninvasive predictors of atherosclerosis: transthoracic coronary flow reserve, flow-mediated dilation, carotid intima-media thickness, aortic stiffness, aortic distensibility, elastic modulus, and brachial artery diameter. Echocardiography (Mount Kisco, NY) 23(10):835–842

    Article  Google Scholar 

  42. Galderisi M, Cicala S, Caso P, De Simone L, D’Errico A, Petrocelli A et al (2002) Coronary flow reserve and myocardial diastolic dysfunction in arterial hypertension. Am J Cardiol 90(8):860–864

    Article  PubMed  Google Scholar 

  43. Barra S, Vitagliano A, Cuomo V, Vitagliano G, Gaeta G (2009) Vascular and metabolic effects of angiotensin II receptor blockers. Expert Opin Pharmacother 10(2):173–189

    Article  CAS  PubMed  Google Scholar 

  44. Lethen H, Tries HP, Kersting S, Bramlage P, Lambertz H (2011) Improvement of coronary microvascular function after Angiotensin receptor blocker treatment with irbesartan in patients with systemic hypertension. J Clin Hypertens (Greenwich, Conn) 13(3):155–161

    Article  CAS  Google Scholar 

  45. Tomas JP, Moya JL, Barrios V, Campuzano R, Guzman G, Megias A et al (2006) Effect of candesartan on coronary flow reserve in patients with systemic hypertension. J Hypertens 24(10):2109–2114

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Author notes

    Authors and Affiliations

    1. Department of Cardiology, Sahlgrenska University Hospital, 4 Bruna Straket, 41345, Gothenburg, Sweden

      Sebastian Völz, Bert Andersson & Bengt Rundqvist

    2. Department of Clinical Physiology, Sahlgrenska University Hospital, 41345, Gothenburg, Sweden

      Sara Svedlund & Gan Li-Ming

    Authors
    1. Sebastian Völz
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. Sara Svedlund
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. Bert Andersson
      View author publications

      You can also search for this author in PubMed Google Scholar

    4. Gan Li-Ming
      View author publications

      You can also search for this author in PubMed Google Scholar

    5. Bengt Rundqvist
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding author

    Correspondence to Sebastian Völz.

    Ethics declarations

    Sources of funding

    This work was supported by a grant from the Gothenburg Medical Society. The funding agency had no role in the design of the study, analysis, interpretation of results, writing of the article, or approval of the article.

    Conflict of interest

    LMG is an employee of Astra Zeneca but has no disclosures in relationship to the current work.

    Additional information

    S. Völz and S. Svedlund contributed equally to this work.

    Rights and permissions

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Völz, S., Svedlund, S., Andersson, B. et al. Coronary flow reserve in patients with resistant hypertension. Clin Res Cardiol 106, 151–157 (2017). https://doi.org/10.1007/s00392-016-1043-4

    Download citation

    • Received:

    • Accepted:

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s00392-016-1043-4

    Keywords

    Search

    Navigation